Not Found
On Demand

2018 AHA/ACC Lipid Guidelines/A New Coronary Artery Disease Predictive Algorithm


Total Credits: 1 including 1 AOA Category 1-A Credit(s)

Average Rating:
   4.7
State Associations:
TOMA - Texas
Faculty:
Robert Megna, DO
Duration:
12/31/2021
Expiration:
Never expires.


Description

This presentation will review the 2018 AHA/ACC Lipid Guidelines for both primary and secondary prevention.

Learning Objectives:

  • Compare the 2018 lipid guidelines to the 2018 National Lipid Association recommendations for lipid management and the 2017 ACE/AACE Lipid Guidelines.
  • Understand the new biomarker algorithm for risk of Acute Coronary Syndrome and its use in clinical practice. 

Statement of Accreditation
The Texas Osteopathic Medical Association (TOMA) is accredited by the American Osteopathic Association to provide osteopathic continuing medical education for physicians. TOMA designates is program for a maximum of 1 AOA Category 1-A credits and will report CME credits commensurate with the extent of the physician’s participation in this activity.

Grievance Policy
All grievances may be directed to TOMA's Executive Director at toma@txosteo.org. All grievances will receive an initial response within 30 days of receipt.  If the participant does not receive a satisfactory response, they can submit a complaint to the Bureau of Osteopathic Education of the AOA at 142 East Ontario Street, Chicago, IL 60611.

Handouts

Faculty

Robert Megna, DO Related seminars and products


Dr. Robert Megna is the owner and director of Cardiovascular Health Solutions, PA. His program specializes in cardivascular and diabetes risk reduction and treatment. Dr. Megna has been in private practice for over thirty years. Dr. Megna is board certified in Family Practice and Integrative Medicine. He is a Diplomate of the American Board of Clinical Lipidology and a Certified Hypertension Specialist. His use of advance laboratory biomarkers and diagnostic procedures provides cutting edge information of his patient's health. He is a popular and prolific national speaker on advanced lipid and carido metabolic biomarkers.

Dr. Megna discloses that he has no relevant financial relationships with any organization producing, marketing, reselling, or distributing health care goods or services consumed by, or used on, patients relative to the content of this presentation.


Please wait ...

Back to Top